Uni-Bio Science Group Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
88.00
73.00
43.00
-20.00
-70.00
5.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-53.00
9.00
-11.00
-5.00
-9.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
68.00
99.00
49.00
12.00
-15.00
-30.00
Cash Flow from Investing Activities
-171.00
-77.00
-28.00
41.00
-25.00
50.00
Cash Flow from Financing Activities
28.00
25.00
2.00
0.00
-5.00
14.00
Net Cash Inflow / Outflow
-64.00
31.00
14.00
58.00
-41.00
34.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
9.00
-16.00
-9.00
3.00
4.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Uni-Bio Science Group Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
88.43
-119.385306312867
207.00
174.07%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-53.483
7.67811381776869
-60.00
-796.56%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
68.87
-78.7006666321291
146.00
187.51%
Cash Flow from Investing Activities
-171.418
-202.174724612182
31.00
15.21%
Cash Flow from Financing Activities
28.978
-7.34258648630115
35.00
494.66%
Net Cash Inflow / Outflow
-64.227
-289.419633754937
225.00
77.81%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
9.343
-1.20165602432559
10.00
877.51%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -30.73% vs 100.51% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
68.87
99.42
-30.73%






